##plugins.themes.academic_pro.article.main##

Abstract

Cardiovascular diseases (CVDs) are the leading cause of disability and death worldwide. In 2020, the WHO reported in Geneva that 17.3 million people died from CVDs, accounting for 30% of all deaths worldwide (WHO report, 2020). Of this number, 7.3 million people died from complications of coronary artery disease (CHD) (World Health Organization, 2021). The study of coronary artery disease, its complications and the effectiveness of treatment dictates the need to study risk factors. It is known that metabolic disorders such as excess body weight, dyslipidemia and impaired glucose metabolism accelerate atherogenesis. All these disorders are components of metabolic syndrome (MS). The issue of the effect of MS on the cardiovascular system has been studied in sufficient detail in the literature, however, the effect of the syndrome on the results of angioplasty procedures and long-term prognosis of coronary artery disease requires further study.

Keywords

Cardiovascular diseases syndrome metabolism

##plugins.themes.academic_pro.article.details##

How to Cite
Shaolimova Z.M, & Jalilov Sh.Z. (2024). Clinical Features and Prognosis Of Coronary Heart Disease In Patients With Metabolic Syndrome. Texas Journal of Medical Science, 37, 29–38. Retrieved from https://zienjournals.com/index.php/tjms/article/view/5628

References

  1. AbdelLatif, A. M. Metabolic syndrome and its impact on cardiovascular complications in patients
  2. who have experienced acute coronary syndrome / A. M. AbdelLatif, T. A. Shishova // Modern
  3. Problems of Science and Education. - 2015. - Issue 1. - P. 1346.
  4. Avaliani, V. M. New insights into the mechanism of atherosclerosis development: literature review /
  5. V. M. Avaliani, V. A. Popov, S. I. Martyushov // Human Ecology. - 2005. - No. 4. - P. 24–29.
  6. Andreev, V. V. The nature of atherosclerotic lesions of the aortoarterial bed in metabolic syndrome /
  7. V. V. Andreev // Preventive and Clinical Medicine. - 2011. - Issue 3. - P. 64-65.
  8. Balzhinimaeva, S. B. Visceral obesity in patients with type 2 diabetes mellitus / S. B. Balzhinimaeva,
  9. A. N. Tsyrenzhapova, D. D. Rabdanova // Bulletin of Medical Internet Conferences. - 2015. - Vol. 5.
  10. No. 5. - P. 516.
  11. Bakhshaliev, A. B. Atherosclerotic damage to the coronary arteries in angina patients with metabolic
  12. syndrome: abstract of dissertation for the degree of Doctor of Medical Sciences: 14.01.04 / A. B.
  13. Bakhshaliev; Institute of Cardiology named after J. Abdullaev of the Ministry of Health of the
  14. Republic of Azerbaijan. - Baku, 2009. - 25 p.
  15. Volkov, V. S. Essential arterial hypertension and arterial hypertension in metabolic syndrome / V. S.
  16. Volkov, O. B. Poselyugina // Clinical Medicine. - 2011. - Vol. 89. No. 2. - P. 64-65.
  17. Gromnatsky, N. I. Features of heart damage in metabolic syndrome in young and middle-aged patients
  18. / N. I. Gromnatsky, G. D. Petrova // Russian Cardiology Journal. - 2007. - Issue 5. - P. 24-27.
  19. Diagnostic assessment of vascular endothelial functional activity in metabolic syndrome and coronary
  20. heart disease / V. A. Nevzorova [et al.] // Cardiovascular Therapy and Prevention. - 2011. - Vol. 10.
  21. No. 2. - P. 81-87.
  22. Features of lipid metabolism in metabolic syndrome / Kovalev A.P. [et al.] // In the collection:
  23. Theoretical and Applied Problems of Modern Science and Education. Materials of the International
  24. Scientific and Practical Conference. - 2015. - P. 92-97.
  25. Srozhidinova, N. Z. The impact of carbohydrate metabolism disorders on cardiovascular risk in
  26. metabolic syndrome / N. Z. Srozhidinova // Cardiovascular Therapy and Prevention. - 2009. - Vol. 8.
  27. No. 6. - P. 341-342.
  28. Chei, C. L. Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke among MiddleAged Japanese / C. L. Chei [et al.] // Hypertens Res. - 2008. - Vol. 31. - P. 1887-1894.
  29. Gruppetta, M. Long-term survival after acute myocardial infarction and relation to type 2 diabetes and
  30. other risk factors / M. Gruppetta, S. Fava, N. Calleja // Clinical Cardiology. - 2010. - Vol. 33, No. 7.
  31. - P. 424-429.